Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CD274: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Gene Symbol | CD274 |
| Pathways | Autophagy-Lysosomal Pathway, autophagy pathway |
| GeneCards | CD274 |
| Human Protein Atlas | CD274 |
| Associated Diseases | CMTM6, BAICALEIN |
| Known Drugs/Compounds | Baicalein, Atezolizumab, Durvalumab, Avelumab, BAICALEIN |
| Interactions | LC3, MAP1LC3B |
| KG Connections | 33 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
CD274["CD274"] -->|"interacts"| LC3["LC3"]
style LC3 fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
CD274["CD274"] -->|"binds"| PDCD1["PDCD1"]
style PDCD1 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
CD274["CD274"] -.->|"inhibits"| T_Cell_Activity["T Cell Activity"]
style T_Cell_Activity fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
CD274["CD274"] -->|"interacts"| MAP1LC3B["MAP1LC3B"]
style MAP1LC3B fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
CD274["CD274"] -->|"involved in"| Autophagic_Lysosomal_Degradati["Autophagic-Lysosomal Degradation"]
style Autophagic_Lysosomal_Degradati fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
CD274["CD274"] -->|"involved in"| Immune_Checkpoint["Immune Checkpoint"]
style Immune_Checkpoint fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
CD274["CD274"] -.->|"inhibits"| T_cell_mediated_immunity["T-cell-mediated immunity"]
style T_cell_mediated_immunity fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
Baicalein["Baicalein"] -->|"targets"| CD274["CD274"]
style Baicalein fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
autophagy_lysosomal_pathway["autophagy-lysosomal pathway"] -->|"promotes"| CD274["CD274"]
style autophagy_lysosomal_pathway fill:#1a2a3a,stroke:#81c784,stroke-width:1px,color:#fff
Atezolizumab["Atezolizumab"] -->|"targets"| CD274["CD274"]
style Atezolizumab fill:#1a2a3a,stroke:#81c784,stroke-width:1px,color:#fff
Durvalumab["Durvalumab"] -->|"targets"| CD274["CD274"]
style Durvalumab fill:#1a2a3a,stroke:#81c784,stroke-width:1px,color:#fff
Avelumab["Avelumab"] -->|"targets"| CD274["CD274"]
style Avelumab fill:#1a2a3a,stroke:#81c784,stroke-width:1px,color:#fff
style CD274 fill:#006494,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold| Target | Relation | Type | Str |
|---|---|---|---|
| LC3 | interacts_with | protein | 0.95 |
| PDCD1 | binds | gene | 0.95 |
| T Cell Activity | inhibits | process | 0.95 |
| MAP1LC3B | interacts_with | protein | 0.90 |
| Autophagic-Lysosomal Degradation | involved_in | process | 0.90 |
| T-cell-mediated immunity | inhibits | process | 0.87 |
| tumor development | promotes | phenotype | 0.85 |
| Autophagy-Lysosomal Pathway | involved_in | pathway | 0.85 |
| T-Cell-Mediated Antitumor Immunity | suppresses | process | 0.85 |
| Cancer | treats | disease | 0.85 |
| Antitumor Immunity | modulates | process | 0.85 |
| Cancer Cell Proliferation | involved_in | process | 0.85 |
| Systemic Immune Suppression | mediates | process | 0.85 |
| T cell exhaustion | promotes | phenotype | 0.85 |
| Cancer Progression | promotes | process | 0.80 |
| autophagy pathway | participates_in | pathway | 0.60 |
| CMTM6 | associated_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Baicalein | targets | compound | 0.95 |
| Baicalein | degrades | compound | 0.95 |
| autophagy-lysosomal pathway | promotes | pathway | 0.92 |
| Atezolizumab | targets | drug | 0.90 |
| Durvalumab | targets | drug | 0.90 |
| Avelumab | targets | drug | 0.90 |
| IFNG | upregulates | gene | 0.90 |
| LC3 | upstream_of | protein | 0.88 |
| baicalein | binds_to | drug | 0.85 |
| Autophagy-Lysosomal Pathway | degrades | pathway | 0.85 |
| MAP1LC3B | binds | protein | 0.85 |
| SPOP | degrades | protein | 0.85 |
| BAICALEIN | activates | drug | 0.65 |
| AUTOPHAGY | regulates | phenotype | 0.65 |
| ATXN3 | co_expressed_with | gene | 0.60 |
| BAICALEIN | associated_with | drug | 0.45 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||